Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase II study of ALLN-177 in adolescents and adults with primary hyperoxaluria or severe forms of secondary hyperoxaluria

Trial Profile

A phase II study of ALLN-177 in adolescents and adults with primary hyperoxaluria or severe forms of secondary hyperoxaluria

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 14 Jan 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Reloxaliase (Primary)
  • Indications Hyperoxaluria; Primary hyperoxaluria
  • Focus Therapeutic Use
  • Acronyms Study 206
  • Sponsors Allena Pharmaceuticals
  • Most Recent Events

    • 08 Jan 2021 Results published in the Nephrology Dialysis Transplantation
    • 18 May 2020 Results (n=14) from this study, were presented at the 115th Annual Meeting of the American Urological Association.
    • 13 May 2020 According to an Allena Pharmaceuticals media release, data from this trial will be presented at the American Urological Association (AUA) Virtual Education Experience, which is being held in place of the cancelled AUA 2020 Annual Meeting.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top